Xiaohong Wang Selected Research

Bone Morphogenetic Protein 2

1/2017	Fabrication of amorphous strontium polyphosphate microparticles that induce mineralization of bone cells in vitro and in vivo.
2/2014	The marine sponge-derived inorganic polymers, biosilica and polyphosphate, as morphogenetically active matrices/scaffolds for the differentiation of human multipotent stromal cells: potential application in 3D printing and distraction osteogenesis.
10/2013	Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro.
1/2013	Inorganic polyphosphates: biologically active biopolymers for biomedical applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohong Wang Research Topics

Disease

95	Neoplasms (Cancer) 07/2022 - 01/2004
68	Polyps 03/2022 - 06/2011
37	Infections 01/2022 - 11/2002
31	Inflammation (Inflammations) 01/2022 - 04/2007
24	Neoplasm Metastasis (Metastasis) 06/2022 - 12/2011
22	Stomach Neoplasms (Stomach Cancer) 06/2022 - 02/2013
16	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2015
13	Carcinogenesis 12/2021 - 04/2009
13	Cysts 01/2017 - 05/2004
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022 - 05/2004
11	Wounds and Injuries (Trauma) 01/2022 - 09/2015
9	Osteoporosis 04/2022 - 01/2011
9	Osteosarcoma (Osteogenic Sarcoma) 10/2021 - 11/2009
9	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2015
9	Ischemia 01/2020 - 06/2008
9	Infarction (Infarctions) 01/2014 - 08/2004
8	Hypoxia (Hypoxemia) 07/2022 - 09/2009
8	Necrosis 01/2020 - 05/2011
8	Myocardial Infarction 01/2012 - 01/2006
7	Nematode Infections 12/2022 - 07/2007
7	Fibrosis (Cirrhosis) 01/2022 - 01/2012
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 05/2015
7	Sepsis (Septicemia) 01/2020 - 09/2009
6	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 12/2012
6	Malaria 11/2021 - 01/2017
6	Human Influenza (Influenza) 08/2021 - 08/2009
6	Hypertrophy 06/2021 - 04/2006
6	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2002
6	Bone Diseases (Bone Disease) 01/2017 - 01/2011
6	Reperfusion Injury 10/2014 - 11/2008
5	Parkinson Disease (Parkinson's Disease) 01/2022 - 05/2008
5	Virus Diseases (Viral Diseases) 01/2022 - 01/2013
5	Body Weight (Weight, Body) 01/2022 - 06/2017
5	Carcinoma (Carcinomatosis) 01/2022 - 01/2015
5	Pancreatitis 10/2021 - 02/2015
5	Cicatrix (Scar) 01/2021 - 05/2010
5	Chronic Hepatitis C 02/2014 - 01/2005
4	Obesity 05/2022 - 12/2012

Drug/Important Bio-Agent (IBA)

75	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2005
67	PolyphosphatesIBA 03/2022 - 08/2012
50	PolymersIBA 01/2022 - 06/2011
23	Alkaline PhosphataseIBA 03/2022 - 06/2011
23	Phosphates (Orthophosphate)IBA 01/2022 - 05/2006
22	Pharmaceutical PreparationsIBA 07/2022 - 04/2002
20	EnzymesIBA 03/2022 - 08/2006
19	Adenosine Triphosphate (ATP)IBA 03/2022 - 08/2006
19	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2008
19	CalciumIBA 09/2021 - 01/2011
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
16	CytokinesIBA 01/2022 - 01/2013
15	Peptides (Polypeptides)IBA 07/2022 - 03/2003
15	Messenger RNA (mRNA)IBA 01/2022 - 01/2004
14	Biological ProductsIBA 03/2022 - 11/2005
14	SaltsIBA 01/2022 - 06/2011
12	CollagenIBA 04/2022 - 02/2014
12	LigandsIBA 11/2021 - 02/2011
11	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2013
11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2011
11	CateninsIBA 12/2021 - 11/2010
11	Therapeutic UsesIBA 08/2021 - 01/2012
10	Biocompatible Materials (Biomaterials)IBA 03/2022 - 06/2009
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2003
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2013
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 01/2013
10	IonsIBA 10/2021 - 05/2014
10	Durapatite (Hydroxylapatite)IBA 12/2020 - 01/2011
9	Phosphotransferases (Kinase)IBA 12/2022 - 10/2011
9	Transcription Factors (Transcription Factor)IBA 06/2021 - 04/2009
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2006
9	VaccinesIBA 01/2019 - 08/2009
8	HydrogelsIBA 01/2022 - 01/2014
8	InterferonsIBA 11/2020 - 01/2005
8	MineralsIBA 01/2019 - 01/2011
8	AntigensIBA 01/2019 - 01/2004
7	Silicon Dioxide (Silica)FDA LinkGeneric 03/2022 - 07/2011
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2011
7	AlginatesIBA 12/2021 - 05/2010
6	SolutionsIBA 01/2022 - 01/2015
6	methylallyl trisulfide (MATS)IBA 01/2022 - 09/2015
6	LipidsIBA 01/2022 - 01/2017
6	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2003
5	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 10/2014
5	6-methyladenineIBA 06/2022 - 12/2019
5	Adenylate KinaseIBA 03/2022 - 10/2018
5	Adenosine Diphosphate (ADP)IBA 01/2022 - 08/2017
5	Fibrinogen (Factor I)FDA Link 01/2022 - 05/2010
5	Amino Acids FDA Link 01/2022 - 04/2013
5	Long Noncoding RNAIBA 01/2022 - 01/2017
5	GelatinIBA 12/2021 - 05/2010
5	ErbB Receptors (EGF Receptor)IBA 04/2021 - 01/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 01/2011
5	GlucocorticoidsIBA 02/2020 - 02/2005
5	LuciferasesIBA 01/2019 - 05/2014

Therapy/Procedure

51	Therapeutics 07/2022 - 08/2004
12	Drug Therapy (Chemotherapy) 07/2022 - 05/2011
8	Radiotherapy 04/2022 - 01/2015
7	Transplantation 01/2012 - 04/2006
6	Ligation 11/2021 - 08/2007
5	Immunotherapy 11/2020 - 09/2014
4	Hysterectomy 03/2022 - 10/2014